Skip to Content Skip to Search
Science, technology and culture gif

Investors

Our investor proposition

GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.

2021 Third quarter results announcement

We announced our third quarter results for the period ended 30 September 2021 on Wednesday 27 October.

Find out more

Latest information

New GSK Investor update

Emma Walmsley, CEO, and other members of CET hosted a virtual investor update on Wednesday 23 June.

The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.

Find out more

Nick Stone appointed SVP Head of Investor Relations

Nick Stone has been appointed Head of Investor Relations, effective 4 October 2021.

Nick joins from AstraZeneca, where he has been leading Investor Relations in Europe, the Americas, and Asia Pacific, along with the sustainability outreach programme. Prior to this, he spent fifteen years in the biopharmaceutical sector, including in the areas of Commercial, Business Development and Corporate Strategy.

A qualified lawyer, Nick will lead IR for New GSK, working closely with the Consumer Healthcare IR team under Sonya Ghobrial in the run-up to the planned separation in mid-2022.

Annual Report 2020

This image represents our technology and was created using real-world data.

We published our Annual Report 2020 on 09 March 2021. View the summary and download the full report or individual sections.

Sign up for announcements

Sign up to receive email notifications when we publish a stock exchange announcement.